Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
OneSource Specialty Pharma: A capacity-led bet on the GLP-1 gold rush
Demand is no longer the question. The only real variable is the timing of regulatory approvals. And on April 21, 2026, that variable moved sharply in the company's favour. Understanding what OneSource builds OneSource Specialty Pharma was demerged…
GoodRx raises 2026 outlook to $765M-$785M revenue and at least $235M adjusted EBITDA, led by Pharma Direct (NASDAQ:GDRX)
Strong Pharma Direct performance, higher subscription growth, and resilient platform engagement are driving the upward revision in revenue and EBITDA guidance, despite continued pressure on legacy prescription transactions revenue. Pharma Direct is…
Former FDA leaders, pharma speak out on mifepristone
After issuing a week-long pause on a federal appeals court decision to stop mail orders of the abortion medication mifepristone, the Supreme Court is expected to take further steps in the case by the end of the day Monday. How the court moves…
Zealand Pharma A/S (OTCMKTS:ZLDPF) Issues Earnings Results
Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.87) earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.96), Zacks reports. Zealand Pharma…
Royalty Pharma (NASDAQ:RPRX) Releases Earnings Results, Beats Estimates By $0.08 EPS
Royalty Pharma (NASDAQ:RPRX - Get Free Report) issued its quarterly earnings data on Wednesday. The biopharmaceutical company reported $1.30 earnings per share for the quarter, topping the consensus estimate of $1.22 by $0.08, Zacks reports. The…
Nxera Files Patent Infringement Action in Relation to its miniG Platform Technology
Tokyo, Japan and Cambridge and London, UK, 8 May 2026 – Nxera Pharma Co., Ltd. (“Nxera Pharma” or “the Company”; TSE 4565) announces that its wholly owned subsidiary Nxera Pharma UK Limited (“Nxera”)…
Sandoz CEO Says Size of Weight-Loss Generics Market Is Unknown
The chief executive of generic-drug maker Group expects the market for unbranded versions of popular weight-loss medicines to be big. Just how big, though, he doesn't dare to forecast. “I've been in generics for 35 years and I've never known…
GoodRx (GDRX) Q1 2026 Earnings Call Transcript
Thursday, May 7, 2026 at 8 a.m. ET Chief Executive Officer — Wendy Barnes Chief Financial Officer — Christopher McGinnis Total Revenue -- $194 million, reflecting growth driven by strategic segments. Adjusted EBITDA -- $58.3 million…
Bruker unveils new NMR products and workflow solutions at ENC 2026
At the Experimental Nuclear Magnetic Resonance Conference (ENC), Bruker Corporation today announced new NMR products and workflow solutions designed to expand performance, sensitivity, and automation across research and applied NMR. The…
Rubber product manufacturers increase prices
Rubber industries have increased the prices of products by 7% as production costs have spiralled because of the U.S.-Israel-Iran war. According to the All India Rubber Industries Association president Anay Gupta, with the production cost increasing…
Iovance Therapeutics: Q1 Earnings Miss May Have Created A Buying Opportunity (NASDAQ:IOVA)
Iovance Biotherapeutics, Inc. markets Amtagvi, a TIL therapy for advanced melanoma, and just reported Q1 earnings. Following Q1 results, IOVA shares declined over 13%, closing at $3.55, with a market cap of $1.59bn. The earnings announcement…
US sending plane for Americans on hantavirus cruise ship
The U.S. will send a charter flight to bring home the remaining 17 Americans who are onboard the hantavirus-stricken MV Hondius cruise ship once it docks off the coast of Spain this weekend. The State Department is arranging a repatriation flight…
Stevanato (STVN) Q1 2026 Earnings Transcript
Thursday, May 7, 2026 at 8:30 a.m. ET Interim CEO — Lisa Miles CFO — Marco Dal Lago Revenue -- EUR 273.6 million, up 10% at constant currency and 7% reported, with growth led by the Biopharmaceutical and Diagnostic Solutions (BDS)…
BridgeBio (BBIO) Q1 2026 Earnings Transcript
Chief Executive Officer — Neil Kumar Chief Commercial Officer — Matthew Outten President and Chief Financial Officer — Thomas Trimarchi Senior Vice President, Strategic Finance — Chinmay Shukla Senior Vice President…
Brian Schimpf has been quietly running Anduril since its earliest days. And once he's talking, he has a lot to say
In 2017, Brian Schimpf was in the California desert with an engineering problem to solve. The place was Apple Valley, expansive, sandy, and surreal. Schimpf—CEO and cofounder of Anduril, then a startup in the truest sense of the…
Receive a Daily briefing on Pharma Industry News
Get Started